This content is from: Canada

ANALYSIS: How GSK’s Canada SC hearing unfolded

The Supreme Court of Canada met last week to hear the Canadian Revenue Authority’s (CRA) appeal and GlaxoSmithKline’s (GSK) response in a case to decide whether GSK paid too much for active pharmaceutical ingredients (API) from a Swiss associated enterprise.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a 30 day period.

REQUEST ACCESS

Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | 30 Day Trial

Related